Gibson, Linda L; Hahner, Lisa; Osborne-Lawrence, Sherri et al. (2005) Molecular basis of estrogen-induced cyclooxygenase type 1 upregulation in endothelial cells. Circ Res 96:518-25
|
Assanasen, Chatchawin; Mineo, Chieko; Seetharam, Divya et al. (2005) Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J Clin Invest 115:969-77
|
Chambliss, Ken L; Simon, Liliana; Yuhanna, Ivan S et al. (2005) Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol: role of ERalpha domains with known nuclear functions. Mol Endocrinol 19:277-89
|
Shaul, Philip W; Mineo, Chieko (2004) HDL action on the vascular wall: is the answer NO? J Clin Invest 113:509-13
|
Shaul, Philip W (2003) Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J Physiol 547:21-33
|
Mineo, Chieko; Yuhanna, Ivan S; Quon, Michael J et al. (2003) High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 278:9142-9
|
Mineo, Chieko; Shaul, Philip W (2003) HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action. Trends Cardiovasc Med 13:226-31
|
Zhu, Yan; Bian, Zhao; Lu, Ping et al. (2002) Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295:505-8
|
Shaul, Philip W (2002) Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64:749-74
|
Chambliss, Ken L; Yuhanna, Ivan S; Anderson, Richard G W et al. (2002) ERbeta has nongenomic action in caveolae. Mol Endocrinol 16:938-46
|
Showing the most recent 10 out of 37 publications